In this paper, we will summarize recent advances in the understanding of the PI3K pathway role in human malignancies, with an emphasis on HNSCC, and discuss the clinical applications and future direction of this field. This evidence concerns the gene PIK3CD and head and neck squamous cell carcinoma.